Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05534984 |
| Consolidated Lead Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 719 participants (ACTUAL) |
| Registered Start Date | 2022-09-08 |
| WhyStopped Classification | Lack of Efficacy / Futility |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, CA | Open Hospital Dossier -> |
| UCLA Health and Jonsson Comprehensive Cancer Center | Los Angeles, CA | Open Hospital Dossier -> |
| UC Davis Comprehensive Cancer Center | Sacramento, CA | Open Hospital Dossier -> |
| UC San Diego Health and Moores Cancer Center | San Diego, CA | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.